- Home
- ASTI vs IBIO Comparison
ASTI vs IBIO Comparison
Compare ASTI & IBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ASTI | IBIO |
|---|---|---|
| Founded | 2005 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 46.8M | 50.4M |
| IPO Year | 2014 | 2009 |
Fundamental Metrics
Financial Performance| Metric | ASTI | IBIO |
|---|---|---|
| Price | $6.68 | $2.69 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $4.00 |
| AVG Volume (30 Days) | ★ 2.6M | 1.1M |
| Earning Date | 01-01-0001 | 05-20-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 69.64 | ★ 73.08 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $10,398,149.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 163.25 | N/A |
| 52 Week Low | $1.17 | $0.56 |
| 52 Week High | $9.87 | $6.89 |
Technical Indicators
Market Signals| Indicator | ASTI | IBIO |
|---|---|---|
| Relative Strength Index (RSI) | 54.59 | 58.66 |
| Support Level | $1.65 | $0.69 |
| Resistance Level | $8.44 | $2.89 |
| Average True Range (ATR) | 1.16 | 0.23 |
| MACD | -0.08 | 0.05 |
| Stochastic Oscillator | 31.78 | 61.54 |
Price Performance
Historical ComparisonAbout ASTI Ascent Solar Technologies Inc.
Ascent Solar Technologies Inc is engaged in the manufacturing, and selling of photovoltaic products (PV) solar modules that are flexible, durable, and possess attractive power-to-weight and power-to-area performance. The company is integrating its PV products into scalable and high-value markets such as agrivoltaics, aerospace, satellites, near-earth orbiting vehicles, and fixed-wing unmanned aerial vehicles (UAV). Ascent is also working to expand its portable solar chargers, such as the XD-12. The company markets and sells its products through OEMs, system integrators, distributors, retailers, and e-commerce companies.
About IBIO iBio Inc.
iBio Inc is a preclinical stage biotechnology company that leverages the power of Artificial Intelligence (AI) for the development of precision antibodies. CDMO. Its technology stack is designed to minimize downstream development risks by employing AI-guided epitope-steering and monoclonal antibody (mAb) optimization.